Article

Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials

SRD Senior Lecturer in Research Synthesis and Nutrition, School of Medicine, University of East Anglia, Health Policy and Practice, Norwich NR4 7TJ, Norfolk, UK.
Human Reproduction Update (Impact Factor: 8.66). 10/2010; 16(6):745-60. DOI: 10.1093/humupd/dmq011
Source: PubMed

ABSTRACT Isoflavones from soy and red clover exert modest hormonal effects in women, but the relevance to risk of breast cancer is unclear. The aim of this meta-analysis was to assess the effects of isoflavone-rich foods or supplements on a biomarker of breast cancer risk, women's mammographic density.
Electronic searches were performed on The Cochrane Library, Medline and EMBASE (to June 2009), and reference lists and trial investigators were consulted to identify further studies. Randomized controlled trials (RCTs) of isoflavone-rich foods or supplements versus placebo with a duration of at least 6 months were included in our analysis. Inclusion/exclusion, data extraction and validity assessment were carried out independently in duplicate, and meta-analysis used to pool study results. Subgrouping, sensitivity analysis, assessment of heterogeneity and funnel plots were used to interpret the results.
Eight RCTs (1287 women) compared isoflavones with placebo for between 6 months and 3 years. Meta-analysis suggested no overall effect of dietary isoflavones on breast density in all women combined [mean difference (MD) 0.69%, 95% confidence interval (CI) -0.78 to 2.17] or post-menopausal women (MD -1.10%, 95% CI -3.22 to 1.03). However, there was a modest increase in mammographic density in premenopausal women (MD 1.83%, 95% CI 0.25-3.40) without heterogeneity but this effect was lost in one of three sensitivity analyses.
Isoflavone intake does not alter breast density in post-menopausal women, but may cause a small increase in breast density in premenopausal women. Larger, long-term trials are required to determine if these small effects are clinically relevant.

Download full-text

Full-text

Available from: Sam J Leinster, Jul 08, 2015
0 Followers
 · 
54 Views
  • Source
    • "mors significantly decreased when prepubertal rats were exposed to soy extracts or the isoflavone genistein ( Warri et al . , 2008 ) . Soy isoflavone is similar to the structure of endogenous estrogen , thus , it is a competitive inhibitor of endogenous estrogen and then protect against breast cancer ( Limer et al . , 2004 ; Magee et al . , 2004 ; Hooper et al . , 2010 ) . Soy isoflavones also have other protective effects , including antioxidant , anti - proliferative , anti - inflammatory and anti - angiogenic effect ( Heber , 2004 ) . A meta - analysis of 47 studies indicated that soy or soy isoflavone can significantly reduce the level of follicle - stimulating hormone and luteinizing hormone in p"
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Evidence for associations between dietary factors and breast cancer risk is inconclusive among Chinese females. To evaluate this question, we conducted a systematic review of relevant case-control and cohort studies. Methods: Studies were systematically searched among 5 English databases (PudMed, ScienceDirect, Wiley, Clinicaltrials.gov, and Cochrane) and 3 Chinese databases (CNKI, WanFang, and VIP) until November 2012. Random effects models were used to estimate summary odds ratios (ORs) and the corresponding 95% confidence intervals (CIs). Results: Thirty one case-control studies and two cohort studies involving 9,299 cases and 11,413 controls were included. Consumption of both soy and fruit was significantly associated with decreased risk of breast cancer, with summary ORs of 0.65 (95% CIs: 0.43-0.99; I2=88.9%, P<0.001; N=13) and 0.66 (95% CIs: 0.47-0.91; I2=76.7%, P<0.001; N=7), respectively. Consumption of fat was significantly associated with increased risk of breast cancer (OR=1.36; 95% CIs: 1.13-1.63; I2=47.9%, P=0.088; N=6). There was non- significant association between consumption of vegetables and breast cancer risk (OR=0.72; 95% CIs: 0.51-1.02; I2= 74.4%, P<0.001; N=9). However, sensitivity analysis based on adjusted ORs showed decreased risk of breast cancer was also associated with consumption of vegetables (OR=0.49; 95% CIs: 0.30-0.67). Conclusion: Both soy food and fruit are significantly associated with decreased risk of breast cancer among Chinese females, and vegetables also seems to be protective while dietary fatexerts a promoting influence.
    Asian Pacific journal of cancer prevention: APJCP 02/2014; 15(3):1291-1298. DOI:10.7314/APJCP.2014.15.3.1291 · 2.51 Impact Factor
  • Source
    • "Epidemiological, clinical, and preclinical (animal) studies have provided ample evidence indicating that breast cancer development can be influenced by diet and lifestyle (Brennan et al. 2010, Patterson et al. 2010). High consumption of soy-rich foods containing genistein (GEN) is considered to partly underlie the lower breast cancer incidence in Asian women than in their western counterparts (Wu et al. 2008, Hooper et al. 2010). The antitumor effects of soy foods and bioactive GEN have been demonstrated in many rodent models of breast cancer (Jin & MacDonald 2002, Simmen et al. 2005, Su et al. 2007b, Verheus et al. 2007, Wu et al. 2008) to occur through multiple mechanisms. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mammary adipose tissue may contribute to breast cancer development and progression by altering neighboring epithelial cell behavior and phenotype through paracrine signaling. Dietary exposure to soy foods is associated with lower mammary tumor risk and reduced body weight and adiposity in humans and in rodent breast cancer models. Despite the suggested linkage between obesity and breast cancer, the local influence of bioactive dietary components on mammary adiposity for anti-tumor effects remains unknown. Herein, we report that post-weaning dietary exposure to soy protein isolate and its bioactive isoflavone genistein lowered mammary adiposity and increased mammary tumor suppressor PTEN and E-cadherin expression in female mice, relative to control casein diet. To ascertain genistein's role in mammary adipose deposition that may affect underlying epithelial cell phenotype, we evaluated genistein's effects on SV40-immortalized mouse mammary stromal fibroblast-like (MSF) cells during differentiation to adipocytes. MSF cultured in differentiation medium with 40 nM genistein showed reductions in mature adipocyte numbers, triglyceride accumulation, and PPARγ and fatty acid synthase transcript levels. Genistein inhibition of adipose differentiation was accompanied by increased estrogen receptor (ER)-β gene expression and was modestly recapitulated by ERβ selective agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN). Reduction of ERβ expression by siRNA targeting increased PPARγ transcript levels and stromal fibroblast differentiation into mature adipocytes; the latter was reversed by genistein but not DPN. Conditioned medium from genistein-treated adipocytes diminished anchorage-independent mammosphere formation of human MCF-7 breast cancer cells. Our results suggest a mechanistic pathway to support direct regulation by genistein of mammary adiposity for breast cancer prevention.
    Journal of Endocrinology 05/2013; DOI:10.1530/JOE-12-0520 · 3.59 Impact Factor
  • Source
    • "Similarly, a randomized control trial within the alpha-Tocopherol, beta-Carotene Cancer Prevention Study (22) suggested flavonoid-rich diets (flavonols, flavan-3-ols, kaempferol, quercetin , catechin, and epicatechin) may decrease pancreatic cancer risk in male smokers who did not consume supplemental alpha-tocopherol and=or beta-carotene. Also, results of the Multiethnic Cohort Study (23) revealed TABLE 4 Meta-analyses on the Effects of Flavonoids on Cancer Risk Tumor=Subtype Outcome Reference Prostate Protective effect of green tea for prostate cancer in one randomized control trial Boehm et al., 2009 (8) Intakes of genistein and daidzein were associated with lower risk of prostate cancer Hwang et al., 2009 (47) Protective effect for green tea but not black tea in Asian populations Zheng et al., 2011 (89) Breast Reduced cancer risk with soy isoflavones in Asian and postmenopausal women Dong and Qin, 2011 (6) Increased breast density in premenopausal women with soy isoflavones Hooper et al., 2010 (135) Small reduction in risk with soy intake Trock et al., 2006 (138) Reduced cancer risk with increased soy intake Wu et al., 2008 (139) Reduced cancer risk with green tea consumption Sun et al., 2006 (90) Trend for reduced risk with green tea consumption of ! 5 cups=d Seely et al., 2005 (91) Lung Reduced risk in some populations Tang et al., 2009 (155) Reduced 18% risk with an increased green tea (2 cups=d) consumption Tang et al., 2009 (92) Ovarian No association between coffee and tea consumption and cancer risk in EPIC study Braem et al., 2012 (97) Trend for a protective effect of green tea Nagle et al., 2010 (93) Protective role of green tea on ovarian and endometrial cancers Butler et al., 2011 (94) No association between tea consumption and risk of ovarian cancer Zhou et al., 2007 (98) No association between tea and coffee drinking and ovarian cancer Steevens et al., 2007 (99) Endometrial Reduced risk by 25% with 2 cups=d Tang et al., 2009 (103) Liver Protective effect of green tea for primary tumors Sing et al., 2011 (95) Gastric Protective effect of green tea (! 5 cups=d) Kang et al., 2010 (96) No association between green tea consumption and cancer risk Zhou et al., 2008 (100) No preventive effect of green tea Myung et al., 2009 (101) Colon No association with green and black tea consumption Sun et al., 2006 (102) Flavonoids and Cancer Prevention 213 the intake of total flavonols, in particular kaempferol, was inversely related to risk of pancreatic cancer (OR for kaempferol ¼ 0.78), although this study had a relative large 95% CI (0.58–1.05). Inverse relationships were also found among current smokers between risk of pancreatic cancer and intake of total flavonols (OR ¼ 0.41), quercetin (OR ¼ 0.55), kaempferol (OR ¼ 0.27), and myricetin (OR ¼ 0.55) (Table 3). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this work is to review data from epidemiological and preclinical studies addressing the potential benefits of diets based on flavonoids for cancer prevention. Flavonoids are subdivided into subclasses including flavonols, flavones, flavanones, flavan-3-ols, anthocyanidins, and isoflavones. Epidemiological studies suggest dietary intake of flavonoids may reduce the risk of tumors of the breast, colon, lung, prostate, and pancreas. However, some studies have reported inconclusive or even harmful associations. A major challenge in the interpretation of epidemiological studies is that most of the data originate from case-control studies and retrospective acquisition of flavonoid intake. Differences in agricultural, sociodemographics, and lifestyle factors contribute to the heterogeneity in the intake of flavonoids among populations residing in the United States, Europe, and Asia. Dose and timing of exposure may influence the anticancer response to flavonoid-rich diets. A limited number of intervention trials of flavonoids have documented cancer preventative effects. Proposed anticancer mechanisms for flavonoids are inhibition of proliferation, inflammation, invasion, metastasis, and activation of apoptosis. Prospective studies with larger sample sizes are needed to develop biomarkers of flavonoid intake and effect. Mechanistic studies are needed to ascertain how flavonoid-rich diets influence gene regulation for cancer prevention.
    07/2012; 31(3):206-38. DOI:10.1080/21551197.2012.702534